Photodynamic therapy (PDT) in the treatment of patients with resistant superficial bladder cancer: A long term experience

Journal of Clinical Laser Medicine and Surgery

Volumn 16, Issue 1, 1998, Pages 61-68

  Nseyo, Unyime O ^a,b,f   DeHaven, Jean ^a   Dougherty, Thomas J ^c   Potter, William R ^c   Merrill, Daniel L ^b,d   Lundahl, Scott L ^b,d,e   Lamm, Donald L ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Lumanectics   (United States)

^f WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLOGY; LASER ABLATION; ONCOLOGY; TOXICITY; UROLOGY;

PHOTOSENSITIZERS; URINARY BLADDER;

PHOTODYNAMIC THERAPY;

PHOTOFRIN; PHOTOFRIN II;

ADULT; AGED; ARTICLE; BLADDER CANCER; CLINICAL TRIAL; CYSTOSCOPY; CYTOLOGY; FEMALE; FOLLOW UP; HUMAN; IMMUNOTHERAPY; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; RECURRENT DISEASE; RETROSPECTIVE STUDY; SAFETY; TREATMENT PLANNING;

EID: 0032006270     PISSN: 10445471     EISSN: None     Source Type: Journal    
DOI: 10.1089/clm.1998.16.61     Document Type: Article

References (31)

1. Traynelis, C.L., and Lamm, D.L. (1994). Current status of intravesical therapy for bladder cancer. In: Rous, S.N. (ed.). Urology Annual Vol. 8, W.W. Norton & Company, New York, London, pp. 113-143.
2. Lamm, D.L. (1995). Prospective advances of BCG in the treatment of superficial bladder cancer. Eur. Urol. (Suppl 1): 2-8.
3. Lamm, D.L. (1992). Carcinoma in situ. Urol. Clinics of NA, 19 (3), 499-508.
4. Nseyo, U.O., and Lamm, D.L. (1996). Therapy of superficial bladder cancer. Seminars in Oncology. 23 (5), 598-604.
5. Coplen, D.E., Marcus, M.D., Myers, J.A., Ratliff, T.L., and Catalona, W.J. (1990). Long-term follow-up of patients treated with 1 or 2, 6 week courses of intravesical bacillus Calmette-Guerin analysis of possible predictors of response free of tumor. J. Urol. 144, 652-657.
6. Bretton, P.R., Herr, H.W., Kimmel, M., et al. (1990). The response of patients with superficial bladder cancer to a second course of intravesical bacillus Calmette-Guerin. J. Urol. 143, 710-713.
7. Badalmet, R. (1992). Recurrent or aggressive bladder cancer: Indications for adjuvant intravesical therapy. Urologic Clinic of NA. 19, 485-498.
8. Dougherty, T.J. (1984). Photodynamic therapy (PDT) of malignant tumors. Crit. Rev. Oncol. Hematol. 2, 83-116.
9. Kessell, D. (1984). Hematoporphyrin and Hpd: Photophysics, photochemistry and phototherapy. Photochem. Photobiol. 39(6), 851-859.
10. Foote, C.S. (1984). Mechanisms of photooxygenation. In: Doiron, D.R., Gober, C.J. (eds.) Porphyrin localization and treatment of tumors. Alan R. Liss, Inc. New York, pp. 3-18.
11. Dougherty, T.J. (1989). Photodynamic therapy: Status and potential. Oncology, 3(7), 67-78.
12. Kelly, J.F., and Snell, M.E. (1976). Hematoporphyrin derivative: A possible aid in the diagnosis and therapy of carcinoma of the bladder. J. Urol. 155, 150-151.
13. Nseyo, U.O., Dougherty, T.J., Potter, W.R., Boyle, D., and Sullivan, L. (1987). Photodynamic therapy in the management of resistant urinary tract carcinoma. Cancer 60, 3113-3119.
14. Nseyo, U.O. (1992). Photodynamic therapy. Urol. Clinics of NA, 19, 591-599.
15. Walther, M.M., Delaney, T.F., Smith, P.D., et al. (1997). A phase I trial of photodynamic therapy in the treatment of recurrent superficial transitional cell carcinoma of the bladder. Urology 50(2), 199-206.
16. Hisazumi, H., Misaki, T., Miyoshi, N., et al. (1983). Photoradiation therapy of bladder tumors. J. Urol. 130, 685-687.
17. Ohi, T., and Tsuchiya, A. (1983). Superficial bladder tumor. In: Hayata, Y., and Dougherty, T.J., (eds). Lasers and hematoporphyrin in cancer. Igaku-shoin, Tokyo, pp. 79-84.
18. Frout, G.R., Lin, C.W., Benson, R., et al. (1987). Photodynamic therapy with Hpd in the treatment of superficial transitional cell carcinoma of the bladder. N. Engl. J. Med. 317, 1251-1255.
19. Benson, R.C., Jr. (1988). Treatment of bladder cancer with hematoporphyrin derivatives and laser light. Urology 23 (Suppl), 13-17.
20. Shumaker, B.P., and Hetzel, F.W. (1987). Clinical laser photodynamic therapy in the treatment of bladder carcinoma. Photochem. Photobiol. 46(5), 899-901.
21. Jocham, D., Beer, M., Baumgartner, R., Staehler, G., and Unsold, E. (1989). Long-term experience with integral photodynamic therapy of TIS bladder carcinoma. Ciba Found. Symp. 146, 198-202.
22. D'Hallewin, M.A., and Baert, L. (1995). Long-term results of whole bladder wall photodynamic therapy for carcinoma-in-situ of the bladder. Urology 45, 763-767.
23. Manyak, M.J., Cole, J.W., McNellis, R.J., and Smith, P.D. (1992). Downstaging of BCG-resistant carcinoma-in-situ of the bladder by photodynamic therapy with intravesical diffusion medium. J. Urol., Part 2. 147, 374A. Abstract 6488.
24. Kreigmar, M., Wiadelich, R., Lumper, W., Ehsan, A., Baumgartner, R., and Hostetter, A. (1995). Integral photodynamic therapy treatment of refractory superficial bladder cancer. J. Urol. 154, 1339-1344.
25. Nseyo, U.O., Crawford, E.D., Shumaker, B., et al. (1995). Photodynamic therapy as an alternative to cystectomy in refractory CIS. Proc. Amer. Assn. Ca. Res. 36, 312 (Abstract 1856).
26. Duggan, M., Crawford, E.D., Nseyo, U.O., Shumaker, B., Harty, J.I., and Hoodin, A. (1991). Photodynamic therapy (PDT) after transurethral resection (TUR) for superficial papillary bladder cancer (SBC): A randomized trial. Proc. Am. Soc. Clin. Oncol. 10, 173 (Abstract 554).
27. Harty, J.I., Amin, M., Weiman, T.J., Tseng, M.T., Ackerman, D., and Broghamen, W. (1989). Complications of whole bladder dihematoporphyrin ether photodynamic therapy. J. Urol. 141, 1341-1346.
28. Windahl, T., and Lofgren, L.A. (1993). Two years' experience with photodynamic therapy of bladder carcinoma. Br. J. Urol. 71, 187-191.
29. Nseyo, U.O., Lundahl, S.L., and Merrill, D.C. (1990). Whole bladder photodynamic therapy: A critical review of present day technology and rationale for development of the intravesical laser catheter and monitoring system. Urology 36, 398-406.
30. Nseyo, U.O., DeBord, J., Kim, H., Tate, K., and DeHaven, J. (1997). Sequential whole bladder photodynamic therapy treatments: A preclinical study. Urol. Onc. 3, 27-30.
31. Potter, W.R., Mang, T.S., and Dougherty, T.J. (1987). The theory of photodynamic therapy dosimetry: Consequences of photodestruction of sensitizer. Photochem. Photobiol. 46, 97-101.